challenges of treating patients with breast cancer with leptomeningeal metastasis
Published 2 years ago • 866 plays • Length 1:20Download video MP4
Download video MP3
Similar videos
-
1:30
tucatinib in her2 breast cancer with leptomeningeal metastases
-
2:32
survival benefit of a combined surgical approach in patients with metastatic breast cancer
-
0:53
the latest news on the management of breast cancer patients with brain metastases
-
6:47
emerging treatments for breast cancer with brain metastases
-
5:55
decision-making in metastatic her2 breast cancer
-
2:47
intrathecal iv nivo for metastatic melanoma with leptomeningeal disease
-
59:51
leptomeningeal disease: overcoming treatment challenges through novel clinical trials
-
2:14
survival in premenopausal hr /her2- breast cancer with micro-metastasis and 21-gene score
-
0:54
do premenopausal patients with breast cancer need chemotherapy?
-
1:15
challenges in tnbc
-
4:42
immune markers predict overall survival in bc patients with brain metastases
-
2:24
the remaining challenges surrounding the use of immunotherapy to treat patients with rectal cancer
-
1:19
gene expression assays to identify patients with breast cancer for neoadjuvant treatment
-
1:36
the tbcrc049 trial for treating leptomeningeal metastases in her2 breast cancer
-
1:50
challenges with patient selection for extended adjuvant endocrine therapy in breast cancer
-
0:36
tucatinib & trastuzumab /- chemo or pembrolizumab in unresectable or metastatic her2 gi cancers
-
1:12
impact of genomic testing on treatment decision-making in breast cancer
-
5:09
use of checkpoint inhibitors in breast cancer treatment
-
2:40
rare brain metastasis: raising leptomeningeal disease awareness | dana-farber cancer institute